We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
51 hedge funds and large institutions have $36.4M invested in CASI Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
82% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 11
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
2% more funds holding
Funds holding: 50 → 51 (+1)
0.08% less ownership
Funds ownership: 1.22% → 1.14% (-0.08%)
2% less capital invested
Capital invested by funds: $37.3M → $36.4M (-$895K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
51
Holders Change
+1
Holders Change %
+2%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
20
Reduced
11
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
WSCM
Wellington Shields Capital Management
New York
|
+$558K |
| 2 |
BlackRock
New York
|
+$397K |
| 3 |
WG
Winton Group
London,
United Kingdom
|
+$171K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$100K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$89.8K |
Top Sellers
| 1 |
WSC
Wellington Shields & Co
New York
|
-$3.6M |
| 2 |
Charles Schwab
San Francisco,
California
|
-$127K |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$122K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$79.7K |
| 5 |
HF
HRT Financial
New York
|
-$53K |
